Innovita Biological Technology Co., Ltd. (SHA:688253)

SHA:688253 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	233.88	307.73	166.46	388.67	479.74	482.06
Trading Asset Securities	1,615	1,584	1,531	1,115	87.25	114.26
Cash & Short-Term Investments	1,849	1,892	1,697	1,503	566.99	596.32
Cash Growth	-0.69%	11.49%	12.89%	165.14%	-4.92%	488.42%
Accounts Receivable	15.75	37.83	105.17	124.31	4.13	9.05
Other Receivables	2.19	1.95	1.68	10.63	0.27	7.55
Receivables	17.95	39.78	106.86	134.95	4.4	16.6
Inventory	43.67	43.47	61.51	74.8	43.63	38.46
Other Current Assets	9.86	22.21	7.2	24.46	32.81	29.11
Total Current Assets	1,920	1,998	1,873	1,738	647.83	680.49
Property, Plant & Equipment	131.19	120.21	118.39	130.29	116.93	66.94
Long-Term Investments	61.74	35.65	34.26	14.94	5	-
Other Intangible Assets	6.61	6.79	7.02	7.25	7.49	3.49
Long-Term Deferred Tax Assets	21.41	22.65	13.41	2.26	1.22	1.71
Long-Term Deferred Charges	9.3	11.19	8.65	12.02	7.31	3.08
Other Long-Term Assets	2.5	18.42	11.31	38.3	12.1	24.35
Total Assets	2,157	2,212	2,066	1,943	797.87	780.06
Accounts Payable	67.7	90.93	63.57	71.56	21.16	9.15
Accrued Expenses	22.87	41.94	25.37	27.44	20.31	54.35
Short-Term Debt	-	-	-	17.62	-	8.8
Current Portion of Leases	-	3.2	1.96	3.01	0.88	-
Current Income Taxes Payable	3.37	0.95	16.34	4.31	2.64	19.41
Current Unearned Revenue	9.81	57.25	100.66	105.1	5.9	12.94
Other Current Liabilities	9.88	15.94	7.34	14.06	1.27	3.64
Total Current Liabilities	116.15	210.21	215.23	243.11	52.15	108.28
Long-Term Leases	2.58	2.57	1.04	2.49	0.52	-
Long-Term Unearned Revenue	2.13	3.14	4.8	6.33	6.99	3.77
Long-Term Deferred Tax Liabilities	3.45	3.15	2.58	1.31	0.05	-
Total Liabilities	124.3	219.07	223.65	253.24	59.7	112.05
Common Stock	136.98	136.46	136.06	136.06	102.04	102.04
Additional Paid-In Capital	1,046	1,036	1,024	1,022	255.67	255.4
Retained Earnings	930.9	874.94	682.51	531.15	380.46	310.21
Treasury Stock	-78.01	-50.01	-	-	-	-
Comprehensive Income & Other	-3.9	-3.65	-1.02	-	-	-
Total Common Equity	2,032	1,993	1,842	1,689	738.17	667.65
Minority Interest	-	-	-	-	-	0.36
Shareholders' Equity	2,032	1,993	1,842	1,689	738.17	668.01
Total Liabilities & Equity	2,157	2,212	2,066	1,943	797.87	780.06
Total Debt	5.09	5.77	3	23.12	1.4	8.8
Net Cash (Debt)	1,844	1,886	1,694	1,480	565.59	587.53
Net Cash Growth	-0.85%	11.35%	14.45%	161.71%	-3.73%	482.62%
Net Cash Per Share	13.46	13.83	12.47	12.18	5.55	5.93
Filing Date Shares Outstanding	138.07	134.87	136.06	136.06	102.04	102.04
Total Common Shares Outstanding	138.07	134.87	136.06	136.06	102.04	102.04
Working Capital	1,804	1,787	1,657	1,494	595.68	572.21
Book Value Per Share	14.72	14.78	13.54	12.42	7.23	6.54
Tangible Book Value	2,022	1,987	1,835	1,682	730.68	664.16
Tangible Book Value Per Share	14.65	14.73	13.49	12.36	7.16	6.51
Buildings	-	97.96	97.96	94.67	85.39	50.22
Machinery	-	98.21	86.21	77.17	61.21	33.97
Construction In Progress	-	2.37	-	-	0.2	2.48

Source: S&P Global Market Intelligence. Standard template. Financial Sources.